S. Collins

Phase I / II Trial of Diaphragm Delivery of Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase ( rAAV 1-CMV-GAA ) Gene Vector in Patients with Pompe Disease

T. Conlon, C. Mah, M. Corti, 2014 .

Transition of care: what is the pediatric hospitalist's role? An exploratory survey of current attitudes.

J. Reiss, A. Saidi, S. Collins, 2012, Journal of hospital medicine.

Inspiratory muscle conditioning exercise and diaphragm gene therapy in Pompe disease: Clinical evidence of respiratory plasticity

B. Byrne, M. Corti, A. Martin, 2017, Experimental Neurology.

B-Cell depletion and immunomodulation before initiation of enzyme replacement therapy blocks the immune response to acid alpha-glucosidase in infantile-onset Pompe disease.

B. Byrne, R. Lawrence, R. Herzog, 2013, The Journal of pediatrics.

Safety of Intradiaphragmatic Delivery of Adeno-Associated Virus-Mediated Alpha-Glucosidase (rAAV1-CMV-hGAA) Gene Therapy in Children Affected by Pompe Disease.

T. Conlon, B. Byrne, I. Tuna, 2017, Human gene therapy. Clinical development.

Phase I/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomes.

T. Conlon, B. Byrne, D. Fuller, 2013, Human gene therapy.

Pompe disease gene therapy.

T. Conlon, B. Byrne, D. Fuller, 2011, Human molecular genetics.

Index of Suspicion in the NurseryCase 1: Abdominal Distention at DeliveryCase 2: Fever and Extreme Respiratory Distress at 11 Days of Age

S. Collins, Heather B. Allewelt, E. Campbell, 2010 .

Implementing a Quality and Safety Agenda in a Children's Hospital Within a Hospital: Challenges and Successes.

Michele N. Lossius, S. Collins, David Hudson, 2016, Hospital pediatrics.

Safety and effectiveness of albuterol solutions with and without benzalkonium chloride when administered by continuous nebulization

M. Ryan, S. Collins, B. Kelly, 2018, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Phase I/II trial of diaphragm delivery of recombinant adeno-associated virus acid alpha-glucosidase (rAAaV1-CMV-GAA) gene vector in patients with Pompe disease.

T. Conlon, M. Corti, S. Collins, 2014, Human gene therapy. Clinical development.